Kidney tissue engineering for precision medicine

2020 ◽  
Vol 16 (11) ◽  
pp. 623-624
Author(s):  
Nanditha Anandakrishnan ◽  
Evren U. Azeloglu
Author(s):  
Bingkun Zhao ◽  
Qian Peng ◽  
Rong Zhou ◽  
Haixia Liu ◽  
Shengcai Qi ◽  
...  

2011 ◽  
pp. 563-573
Author(s):  
L.S. Krane ◽  
T. Aboushwareb ◽  
A. Atala

PLoS ONE ◽  
2019 ◽  
Vol 14 (5) ◽  
pp. e0216564 ◽  
Author(s):  
Michael E. Bregenzer ◽  
Eric N. Horst ◽  
Pooja Mehta ◽  
Caymen M. Novak ◽  
Shreya Raghavan ◽  
...  

Author(s):  
Mohammad Amin Keshvari ◽  
Alireza Afshar ◽  
Sajad Daneshi ◽  
Arezoo Khoradmehr ◽  
Mandana Baghban ◽  
...  

Chronic kidney diseases (CKD) and end stage renal disease (ESRD) are growing threats worldwide. Tissue engineering is a new hope to surpass the current limitations such as the shortage of donor. To do so, the first step would be fabrication of an intact decellularized kidney scaffold. In the current study, an automatic decellularization device was developed to perfuse and decellularize male rats' kidneys using both sodium lauryl ether sulfate (SLES) and sodium dodecyl sulfate (SDS) and to compare their efficacy in kidney decellularization and post-transplantation angiogenesis. After anesthesia, kidneys were perfused with either 1% SDS solution for 4 h or 1% SLES solution for 6 h. The decellularized scaffolds were stained with hematoxylin and eosin (H&E), periodic acid Schiff (PAS), Masson’s trichrome, and alcian blue to determine cell removal and glycogen, collagen and glycosaminoglycans (GAGs) contents, respectively. Moreover, scanning electron microscopy (SEM) was performed to evaluate the cell removal and preservation of microarchitecture of both SDS and SLES scaffolds. Additionally, DNA quantification assay was applied for all groups in order to measure residual DNA in the scaffolds and normal kidney. In order to demonstrate biocompatibility and bioactivity of the decellularized scaffolds, allotransplantation was performed in back muscle and angiogenesis was evaluated. Complete cell removal in both SLES and SDS groups was observed in SEM and DNA quantification assays. Moreover, the extracellular matrix (ECM) architecture of rat kidney in the SLES group was significantly preservation better than the SDS group was shown. The formation of blood capillaries and vessels were observed in the kidney allotransplantations in both SLES and SDS decellularized kidneys. In conclusion, we demonstrated that both SLES and SDS could be promising tools in kidney tissue engineering. The better preservation of ECM than SDS, introduces SLES as the solvent of choice for kidney decellularization. ¬¬


Author(s):  
Büsra Baskapan ◽  
Anthony Callanan

Abstract BACKGROUND: Today’s treatment options for renal diseases fall behind the need, as the number of patients has increased considerably over the last few decades. Tissue engineering (TE) is one avenue which may provide a new approach for renal disease treatment. This involves creating a niche where seeded cells can function in an intended way. One approach to TE is combining natural extracellular matrix proteins with synthetic polymers, which has been shown to have many positives, yet a little is understood in kidney. Herein, we investigate the incorporation of laminin into polycaprolactone electrospun scaffolds. METHOD: The scaffolds were enriched with laminin via either direct blending with polymer solution or in a form of emulsion with a surfactant. Renal epithelial cells (RC-124) were cultured on scaffolds up to 21 days. RESULTS: Mechanical characterization demonstrated that the addition of the protein changed Young’s modulus of polymeric fibres. Cell viability and DNA quantification tests revealed the capability of the scaffolds to maintain cell survival up to 3 weeks in culture. Gene expression analysis indicated healthy cells via three key markers. CONCLUSION: Our results show the importance of hybrid scaffolds for kidney tissue engineering.


2018 ◽  
Vol 38 (1) ◽  
pp. 40-51 ◽  
Author(s):  
Krzysztof Kiryluk ◽  
Andrew S. Bomback ◽  
Yim-Ling Cheng ◽  
Katherine Xu ◽  
Pablo G. Camara ◽  
...  

Biomimetics ◽  
2021 ◽  
Vol 6 (2) ◽  
pp. 40
Author(s):  
Charlotta G. Lebedenko ◽  
Ipsita A. Banerjee

Chronic kidney diseases are a leading cause of fatalities around the world. As the most sought-after organ for transplantation, the kidney is of immense importance in the field of tissue engineering. The primary obstacle to the development of clinically relevant tissue engineered kidneys is precise vascularization due to the organ’s large size and complexity. Current attempts at whole-kidney tissue engineering include the repopulation of decellularized kidney extracellular matrices or vascular corrosion casts, but these approaches do not eliminate the need for a donor organ. Stem cell-based approaches, such as kidney organoids vascularized in microphysiological systems, aim to construct a kidney without the need for organ donation. These organ-on-a-chip models show complex, functioning kidney structures, albeit at a small scale. Novel methodologies for developing engineered scaffolds will allow for improved differentiation of kidney stem cells and organoids into larger kidney grafts with clinical applications. While currently, kidney tissue engineering remains mostly limited to individual renal structures or small organoids, further developments in vascularization techniques, with technologies such as organoids in microfluidic systems, could potentially open doors for a large-scale growth of whole engineered kidneys for transplantation.


Sign in / Sign up

Export Citation Format

Share Document